The Third Department of Orthopedics, The Fifth Hospital of Harbin, Harbin, 150040, Heilongjiang Province, PR China.
Operating Theater, The Fifth Hospital of Harbin, Harbin, 150040, Heilongjiang Province, PR China.
Biochimie. 2019 Aug;163:1-11. doi: 10.1016/j.biochi.2019.04.017. Epub 2019 Apr 16.
Osteosarcoma is an aggressive bone tumor characterized by a high level of genetic instability and recurring DNA deletions and amplifications. This study aims to investigate how microRNA-496 (miR-496) affects proliferation, invasion, and migration of human osteosarcoma (OS) cells and in vivo tumorigenicity by targeting eukaryotic translation initiation factor 4E (eIF4E). Microarray-based gene expression profiling involving OS was used in order to identify differentially expressed genes. After that, the interaction between miR-496 expression and OS patients' survival rate was determined. The expression pattern of miR-496 and eIF4E was determined in OS tissues and cells, and their potential relationship was further analyzed by using the dual luciferase reporter gene assay. With the purpose of identifying the functional role miR-496 in OS, cell proliferation, migration, and invasion were measured in cells treated with miR-496 mimic or inhibitor. A nude mouse model was constructed in order to investigate the regulatory effects of miR-496 on tumor growth in vivo by regulating eIF4E. OS cells exhibited a down-regulated expression of miR-496 and an up-regulated expression of eIF4E. miR-496 expression was positively correlated to OS patients' survival rate. Bioinformatics analysis suggested eIF4E would be a direct target of miR-496, and the expression of eIF4E was inhibited by overexpression of miR-496. miR-496 elevation was found to exert suppressive effects on OS cell proliferation, migration and invasion in vitro and tumor growth in vivo, with the effects being reversed using miR-496 depletion. Altogether, the above findings support a conclusion that miR-496 could work as a tumor suppressor in OS through down-regulation of eIF4E. This study may provide a novel target for treatment of OS.
骨肉瘤是一种具有高水平遗传不稳定性和反复出现的 DNA 缺失和扩增的侵袭性骨肿瘤。本研究旨在通过靶向真核翻译起始因子 4E(eIF4E)来研究 microRNA-496(miR-496)如何影响人骨肉瘤(OS)细胞的增殖、侵袭和迁移以及体内肿瘤生成能力。使用基于微阵列的基因表达谱分析来鉴定差异表达基因。之后,确定 miR-496 表达与 OS 患者生存率之间的相互作用。确定 miR-496 和 eIF4E 在 OS 组织和细胞中的表达模式,并通过双荧光素酶报告基因检测进一步分析它们之间的潜在关系。为了确定 miR-496 在 OS 中的功能作用,在转染 miR-496 模拟物或抑制剂的细胞中测量细胞增殖、迁移和侵袭。构建裸鼠模型,通过调节 eIF4E 来研究 miR-496 在体内对肿瘤生长的调节作用。OS 细胞表现出 miR-496 的下调表达和 eIF4E 的上调表达。miR-496 的表达与 OS 患者的生存率呈正相关。生物信息学分析表明 eIF4E 是 miR-496 的直接靶标,miR-496 的过表达抑制了 eIF4E 的表达。发现 miR-496 升高可在体外抑制 OS 细胞的增殖、迁移和侵袭,并在体内抑制肿瘤生长,而 miR-496 耗竭则逆转了这些作用。总之,上述发现表明 miR-496 可通过下调 eIF4E 在 OS 中发挥肿瘤抑制作用。本研究可能为 OS 的治疗提供新的靶点。